Breaking News Instant updates and real-time market news.

NVS

Novartis

$86.24

0.9 (1.05%)

20:26
10/18/18
10/18
20:26
10/18/18
20:26

Novartis granted orphan status for melanoma treatment

The FDA granted Novartis orphan status for spartalizumab, its treatment of of stage IIB-IV melanoma. Reference Link

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

NVS Novartis
$86.24

0.9 (1.05%)

10/16/18
WELS
10/16/18
NO CHANGE
WELS
Drug price in ads not impactful, may cause confusion, says Wells Fargo
Wells Fargo analyst David Maris acknowledges that the U.S. Department of Health and Human Services' proposal to include drug prices in advertisements has a "noble goal" of making drugs more affordable and keeping patients well informed. However, given how different list prices are relative to out of pocket costs, "one must ask if this is increasing transparency or likely going to lead to more confusion," he contends. The analyst also believes that the unintended consequence could be worse care, while noting that the drug price information will likely fall into the category of the side effect information in drug ads currently, tuned out by many and will have no material impact. While he supports the idea of increased transparency, Maris wonders whether the potential benefit is not outweighed by the potential negative for the most vulnerable. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
10/18/18
HCWC
10/18/18
NO CHANGE
Target $280
HCWC
Buy
Ligand current valuation brings attractive entry point, says H.C. Wainwright
Ligand Pharmaceuticals (LGND) partner Novartis (NVS) announced this morning Q3 Promacta revenue of $295M, H.C. Wainwright analyst Joseph Pantginis tells investors in a research note. The sales missed his estimate of $318M and came close to the consensus of $295.8M. Importantly, in the first nine months of 2018, Promacta total sales were $844M, representing 37% growth for the first nine-month period in 2017, the analyst points out. He continues to be impressed with the Promacta franchise, which he notes represents a cornerstone of Ligand's royalty revenue for the long term. Pantginis believes the recent pullback in shares of Ligand presents an attractive entry point and "compelling accumulation opportunity." He reiterates a Buy rating on the name with a $280 price target.
10/18/18
WELS
10/18/18
NO CHANGE
WELS
Sandoz results 'potential warning signal' for generics, says Wells Fargo
Wells Fargo analyst David Maris views this morning's results from Novartis' (NVS) generic unit Sandoz as "another negative datapoint" for generic stocks, notably Teva (TEVA), Mylan (MYL) and Amneal Pharmaceuticals (AMNX). Novartis reported Sandoz net sales of $2.4B, down 4% on constant currency, and noted that sales were pressured by 8% pricing erosion in the quarter, Maris tells investors in a research note. Novartis also highlighted that U.S sales for Sandoz declined 17% due to "industry wide pricing pressure," Maris points out. The analyst views the quarter as a "potential warning signal" for the Q3 earnings season for companies with large U.S. commodity generic exposure. He maintains his caution on "generic industry margin risks."
10/18/18
WEDB
10/18/18
DOWNGRADE
WEDB
Neutral
Endocyte downgraded to Neutral from Outperform at Wedbush
Wedbush analyst David Nierengarten downgraded Endocyte (ECYT) to Neutral after the company agreed to be acquired by Novartis (NVS) for $24 per share. The analyst does not next another bidder to emerge.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
03/19/19
03/19
13:17
03/19/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
03/19/19
03/19
13:16
03/19/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,188.47

4.81 (0.41%)

, GOOGL

Alphabet Class A

$1,191.43

3.34 (0.28%)

13:10
03/19/19
03/19
13:10
03/19/19
13:10
Hot Stocks
Google CEO says aiming to build a game platform 'for everyone' »

Google (GOOG) CEO Sundar…

GOOG

Alphabet

$1,188.47

4.81 (0.41%)

GOOGL

Alphabet Class A

$1,191.43

3.34 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

NOG

Northern Oil and Gas

$2.47

0.01 (0.41%)

13:10
03/19/19
03/19
13:10
03/19/19
13:10
Options
Notable spread in Northern Oil and Gas »

Notable spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$282.92

0.46 (0.16%)

13:08
03/19/19
03/19
13:08
03/19/19
13:08
Periodicals
U.S., China trade talks in final stages, WSJ reports »

The trade talks between…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$282.92

0.46 (0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$33.10

-0.01 (-0.03%)

13:05
03/19/19
03/19
13:05
03/19/19
13:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
03/19/19
03/19
13:05
03/19/19
13:05
General news
Treasury Action: trade worries are putting a bid in Treasuries »

Treasury Action: trade…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$283.29

0.83 (0.29%)

13:03
03/19/19
03/19
13:03
03/19/19
13:03
Periodicals
Markets drop after Bloomberg report on China walking back some trade offers 

Reference Link

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$283.29

0.83 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WSM

Williams-Sonoma

$57.42

1.01 (1.79%)

12:55
03/19/19
03/19
12:55
03/19/19
12:55
Options
Williams Sonoma put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

ZNGA

Zynga

$5.37

0.02 (0.37%)

, AMZN

Amazon.com

$1,782.25

40.25 (2.31%)

12:52
03/19/19
03/19
12:52
03/19/19
12:52
Periodicals
Amazon focuses on building game industry's digital infrastructure, Variety says »

Amazon (AMZN), which owns…

ZNGA

Zynga

$5.37

0.02 (0.37%)

AMZN

Amazon.com

$1,782.25

40.25 (2.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

SPY

SPDR S&P 500 ETF Trust

$283.90

1.44 (0.51%)

, SPX

S&P 500

$0.00

(0.00%)

12:50
03/19/19
03/19
12:50
03/19/19
12:50
Periodicals
Some U.S. officials see China walking back trade offers, Bloomberg reports »

Some U.S. officials are…

SPY

SPDR S&P 500 ETF Trust

$283.90

1.44 (0.51%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$284.09

1.63 (0.58%)

, SPX

S&P 500

$0.00

(0.00%)

12:47
03/19/19
03/19
12:47
03/19/19
12:47
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

Some U.S. officials see…

SPY

SPDR S&P 500 ETF Trust

$284.09

1.63 (0.58%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$6.70

0.27 (4.20%)

12:45
03/19/19
03/19
12:45
03/19/19
12:45
Options
SunPower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$201.50

-4.35 (-2.11%)

12:35
03/19/19
03/19
12:35
03/19/19
12:35
Options
Shopify put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBKC

Iberiabank

$76.60

-1.23 (-1.58%)

12:32
03/19/19
03/19
12:32
03/19/19
12:32
Hot Stocks
Iberiabank board of directors raises quarterly dividend 5% to 43c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

, MSFT

Microsoft

$117.78

0.18 (0.15%)

12:26
03/19/19
03/19
12:26
03/19/19
12:26
On The Fly
Game On: An exclusive talk with The Voxel Agents' Simon Joslin »

'GARDENS BETWEEN': In an…

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$117.78

0.18 (0.15%)

SNE

Sony

$46.20

0.105 (0.23%)

FB

Facebook

$163.32

2.86 (1.78%)

TCEHY

Tencent

$0.00

(0.00%)

ATVI

Activision Blizzard

$46.95

1.98 (4.40%)

TTWO

Take-Two

$96.16

2.4 (2.56%)

EA

Electronic Arts

$98.79

-0.9 (-0.90%)

UBSFY

Ubisoft

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

PBR

Petrobras

$17.49

0.38 (2.22%)

12:25
03/19/19
03/19
12:25
03/19/19
12:25
Options
Petrobras call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,194.39

10.73 (0.91%)

, GOOGL

Alphabet Class A

$1,198.03

9.94 (0.84%)

12:21
03/19/19
03/19
12:21
03/19/19
12:21
Periodicals
'Cheaper' Google Pixel may be coming, Mashable says »

Citing prior reports…

GOOG

Alphabet

$1,194.39

10.73 (0.91%)

GOOGL

Alphabet Class A

$1,198.03

9.94 (0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

CPRX

Catalyst Pharmaceuticals

$3.40

0.31 (10.03%)

12:21
03/19/19
03/19
12:21
03/19/19
12:21
Recommendations
Catalyst Pharmaceuticals analyst commentary  »

Catalyst comments point…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 19

    Mar

NVDA

Nvidia

$175.42

6.51 (3.85%)

12:20
03/19/19
03/19
12:20
03/19/19
12:20
Hot Stocks
Nvidia up 4% as executives present at investor day meeting »

Nvidia said during the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

BRQS

Borqs Technologies

$4.22

(0.00%)

12:20
03/19/19
03/19
12:20
03/19/19
12:20
Hot Stocks
Breaking Hot Stocks news story on Borqs Technologies »

Borqs Technologies Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
03/19/19
03/19
12:17
03/19/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
03/19/19
03/19
12:16
03/19/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRQS

Borqs Technologies

$4.22

(0.00%)

12:15
03/19/19
03/19
12:15
03/19/19
12:15
Hot Stocks
Breaking Hot Stocks news story on Borqs Technologies »

Borqs Technologies Inc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:15
03/19/19
03/19
12:15
03/19/19
12:15
General news
The CNBC Fed survey »

The CNBC Fed survey has…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.